Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Cytogenetics and molecular genetics"'
Autor:
Yolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, Gemma Osca-Gelis, Marta González-Bártulos, Francesca Llopis, Victòria Clapes, Albert Oriol, Anna Sureda, Lourdes Escoda, Josep Sarrà, Ana Garzó, Natàlia Lloveras, Isabel Díez, Isabel Granada, David Gallardo
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Immune dysfunction in patients with multiple myeloma (MM) affects both the innate and adaptive immune system. Molecules involved in the immune checkpoint pathways are essential to determine the ability of cancer cells to escape from the immune system
Externí odkaz:
https://doaj.org/article/83514f73742b4cc29f8593d7f6b6b27a
Autor:
Benjamin Fournier, Estelle Balducci, Nicolas Duployez, Emmanuelle Clappier, Wendy Cuccuini, Chloé Arfeuille, Aurélie Caye-Eude, Eric Delabesse, Elodie Bottollier-Lemallaz Colomb, Karin Nebral, Marie-Lorraine Chrétien, Coralie Derrieux, Aurélie Cabannes-Hamy, Florent Dumezy, Pascaline Etancelin, Odile Fenneteau, Jamile Frayfer, Antoine Gourmel, Marie Loosveld, Gérard Michel, Nathalie Nadal, Dominique Penther, Isabelle Tigaud, Elise Fournier, Bettina Reismüller, Andishe Attarbaschi, Marina Lafage-Pochitaloff, André Baruchel
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: B-cell acute lymphoblastic leukemia associated with t(5;14)(q31;q32); IGH-IL3 is an exceptional cause of eosinophilia. The IGH enhancer on 14q32 is juxtaposed to the IL3 gene on 5q31, leading to interleukin-3 overproduction and release of
Externí odkaz:
https://doaj.org/article/1b4b31d6c5cc45dd877c16f2db254e22
Publikováno v:
Clinical Case Reports, Vol 7, Iss 9, Pp 1823-1824 (2019)
Abstract Burkitt‐like lymphoma with 11q aberration is a recently recognized diagnostic entity in the Revised 4th Edition of the World Health Organization (WHO) classification of lymphoid neoplasms. This diagnosis should be considered and cytogeneti
Externí odkaz:
https://doaj.org/article/847e4d0bd97b40a69429d1403d8572b8
Autor:
Anna Michelato, Fabio Ciceri, Dario Ferrero, Lorella De Paoli, Renato Bassan, Chiara Caprioli, Paolo Corradini, Silvia Salmoiraghi, Brunangelo Falini, Chiara Cattaneo, Giacomo Gianfaldoni, Agostino Cortelezzi, Federica Delaini, Alessandro Rambaldi, Francesco Mannelli, Leonardo Campiotti, Anna Maria Scattolin, Pamela Zanghì, Erika Borlenghi, Federico Lussana, Massimo Bernardi, Ksenija Buklijas, Daniele Mattei, Elena Oldani, Monica Tajana, Tamara Intermesoli, Roberta Cavagna, Anna De Grassi, Irene Cavattoni, Ernesta Audisio, Elisabetta Terruzzi, Orietta Spinelli, Lara Elidi, Elisabetta Todisco, Chiara Pavoni
Publikováno v:
Haematologica
Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history or specific morphological and cytogenetic abnormalities. However, in the absence of these f
Autor:
Sutton, Lesley-Ann, Ljungström, Viktor, Enjuanes, Anna, Cortese, Diego, Skaftason, Aron, Tausch, Eugen, Kozubik, Katerina Stano, Nadeu, Ferran, Armand, Marine, Malcikova, Jikta, Djureinovic, Tatjana, Forster, Jade, Davis, Zadie, Oscier, David, Rossi, Davide, Ghia, Paolo, Strefford, Jonathan C., Pospisilova, Sarka, Stilgenbauer, Stephan, Davi, Frederic, Campo, Elias, Stamatopoulos, Kostas, Rosenquist, Richard
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, 106 (3), pp.682-691. ⟨10.3324/haematol.2019.234716⟩
Haematologica, Ferrata Storti Foundation, 2020, 106 (3), pp.682-691. ⟨10.3324/haematol.2019.234716⟩
International audience; Next-generation sequencing (NGS) has transitioned from research to clinical routine, yet the comparability of different technologies for mutation profiling remains an open question. We performed a European multicenter (n=6) ev
Autor:
J. Lequesne, Marie Cornic, Stéphane Leprêtre, Lucile Bessi, Elena-Liana Veresezan, Elodie Bohers, Justine Loret, Anne-Lise Menard, Hervé Tilly, Nathalie Contentin, Pierre-Julien Viailly, Aspasia Stamatoullas, Vincent Camus, Stéphanie Becker, Jean-Michel Picquenot, Hélène Lanic, Pierre Decazes, Sydney Dubois, Pascaline Etancelin, Pascal Lenain, Mathieu Viennot, Bénédicte Marcq, Fabrice Jardin, Emilie Lemasle, Lucie Burel
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2021, 106 (1), pp.154-162. ⟨10.3324/haematol.2019.237719⟩
Haematologica, Ferrata Storti Foundation, 2021, 106 (1), pp.154-162. ⟨10.3324/haematol.2019.237719⟩
The relevance of circulating tumor DNA (ctDNA) analysis as a liquid biopsy and minimal residual disease tool in the management of classical Hodgkin lymphoma (cHL) patients was demonstrated in retrospective settings and remains to be confirmed in a pr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Edoardo Botteri, Massimo Breccia, Vincenzo Bagnardi, Teresa Bernal, Pau Montesinos, Pier Giuseppe Pelicci, Luca Mazzarella, Timothy J. Ley, Davide Di Salvatore, Cristina Gil, Krishnan Bhaskaran, Francesco Lo Coco, Miguel A. Sanz, Elena Gatti, Anthony Matthews
Publikováno v:
Haematologica
Obesity correlates with hematologic malignancies including leukemias, but risk of specific leukemia subtypes like acute promyelocytic leukemia and underlying molecular mechanisms are poorly understood. We explored multiple datasets for correlation be
Autor:
Jane F. Apperley, Georgios Nteliopoulos, Dragana Milojkovic, Simone Claudiani, George Nesr, Letizia Foroni, Adi Shacham Abulafia, Richard Szydlo, Jamshid S. Khorashad, Renuka Palanicawandar, Aoife Gatenby
Publikováno v:
Haematologica
The majority of patients with newly diagnosed chronic myeloid leukemia (CML) will enjoy a life expectancy equivalent to that of unaffected individuals, but will remain on life-long treatment with a concomitant requirement for on-going hospital intera
Autor:
Touzart, Aurore, Boissel, Nicolas, Belhocine, Mohamed, Smith, Charlotte, Graux, Carlos, Latiri, Mehdi, Lhermitte, Ludovic, Mathieu, Ève-Lyne, Huguet, Francoise, Lamant, Laurence, Ferrier, Pierre, Ifrah, Norbert, Macintyre, Elizabeth, Dombret, Herve, Asnafi, Vahid, Spicuglia, Salvatore
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, Ferrata Storti Foundation, 2019, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, 2020, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, Vol. 105, no. 6, p. 1575-1581 (2020)
Haematologica, Ferrata Storti Foundation, 2020, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, Ferrata Storti Foundation, 2019, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, 2020, pp.haematol.2019.223677. ⟨10.3324/haematol.2019.223677⟩
Haematologica, Vol. 105, no. 6, p. 1575-1581 (2020)
Cancer cells undergo massive alterations in their DNA methylation patterns which result in aberrant gene expression and malignant phenotypes. Abnormal DNA methylation is a prognostic marker in several malignancies, but its potential prognostic signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a834db0c67fcd3cd49e8ac0bcc92ccd5
https://hal-amu.archives-ouvertes.fr/hal-02351125/document
https://hal-amu.archives-ouvertes.fr/hal-02351125/document